Yang Qiumei, Chan Piu
1Department of Neurology, Geriatrics and Neurobiology, National Clinical Research Center of Geriatric Disorders, Xuanwu Hospital of Capital Medical University, Beijing, China.
4Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
Aging Dis. 2022 Jun 1;13(3):801-814. doi: 10.14336/AD.2021.1107. eCollection 2022 Jun.
Sarcopenia is a new type of senile syndrome with progressive skeletal muscle mass loss with age, accompanied by decreased muscle strength and/or muscle function. Sarcopenia poses a serious threat to the health of the elderly and increases the burden of family and society. The underlying pathophysiological mechanisms of sarcopenia are still unclear. Recent studies have shown that changes of skeletal muscle metabolism are the risk factors for sarcopenia. Furthermore, the importance of the skeletal muscle metabolic microenvironment in regulating satellite cells (SCs) is gaining significant attention. Skeletal muscle metabolism has intrinsic relationship with the regulation of skeletal muscle mass and regeneration. This review is to discuss recent findings regarding skeletal muscle metabolic alternation and the development of sarcopenia, hoping to contribute better understanding and treatment of sarcopenia.
肌肉减少症是一种新型的老年综合征,随着年龄增长,骨骼肌质量逐渐丧失,并伴有肌肉力量和/或肌肉功能下降。肌肉减少症对老年人的健康构成严重威胁,增加了家庭和社会的负担。肌肉减少症的潜在病理生理机制仍不清楚。最近的研究表明,骨骼肌代谢变化是肌肉减少症的危险因素。此外,骨骼肌代谢微环境在调节卫星细胞方面的重要性正受到广泛关注。骨骼肌代谢与骨骼肌质量和再生的调节有着内在联系。本综述旨在讨论骨骼肌代谢改变与肌肉减少症发展的最新研究结果,希望有助于更好地理解和治疗肌肉减少症。